Daxor Corp. (DXR)
-NYSE MKT 7.20 0.00(0.00%) Jun 17, 4:00PM EDT
| Prev Close: | 7.30 |
|---|
| Open: | N/A |
|---|
| Bid: | 7.16 x 100 |
|---|
| Ask: | 10.00 x 1300 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | -0.02 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 7.06 - 9.50 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 1,122 |
|---|
| Market Cap: | 29.76M |
|---|
| P/E (ttm): | 25.09 |
|---|
| EPS (ttm): | 0.29 |
|---|
| Div & Yield: | 0.40 (5.50%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Daxor Corporation Announces the Bi-Monthly Publication of a Medical Column by Its President, Dr. Joseph FeldschuhMarketwired(Thu, Jun 13)
- Daxor Corporation Announces Placement of BVA-100 Blood Volume Analyzer at Austin Nuclear Pharmacy, Inc.Marketwired(Thu, May 16)
- 4 Obscure Healthcare Stocks To Watch In 2013at Seeking Alpha(Mon, May 13)
- Heartbeat Clinic in Dallas Acquires Blood Volume Analyzer; Daxor Corporation Announces 250,000 Share BuybackMarketwired(Thu, Mar 21)
- 3 Speculative Healthcare Companies With High Levels Of Insider Ownership - Part IIat Seeking Alpha(Mon, Mar 11)
- Daxor Corporation Announces the Sale of a BVA-100 Blood Volume Analyzer to Banner Good Samaritan Medical Center of Phoenix, ArizonaMarketwired(Thu, Mar 7)
- Daxor Corporation Announces Filing of Form N-CSR for December 31, 2012 and Volumex Kit Sales for 2012Marketwired(Fri, Mar 1)
- Reports of a Study Comparing Daxor's Direct Blood Volume Measurement With a Non-Invasive Hemoglobin Monitor in Critically Ill Surgical PatientsMarketwired(Thu, Feb 14)
- A Study Evaluating Hyponatremia Utilizing the BVA-100 Is Presented at Annual 2013 Critical Care CongressMarketwired(Thu, Jan 31)
- Reminder - Daxor (DXR) Goes Ex-Dividend Soonat Forbes(Wed, Dec 5)
- Daxor Corporation Announces Payment of a DividendMarketwired(Thu, Nov 29)
- Daxor Announces That PCI Nuclear Pharmacy Acquires BVA-100 Blood Volume AnalyzerMarketwired(Mon, Nov 19)
- Daxor Announces Basic Blood Volume Research Study on Renal Dialysis PatientsMarketwired(Thu, Nov 8)
- 5 Healthcare Companies With Insider Buying During October 2012at Seeking Alpha(Mon, Oct 15)
- 4 Stocks That Insiders Bought From October 8-12 To Considerat Seeking Alpha(Sun, Oct 14)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 12.58 |
|---|
| Ex-Dividend Date: | 07-Dec-12 |
|---|
Analysts
| Annual EPS Est
()
: | N/A |
|---|
| Quarterly EPS Est
()
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Daxor Corporation, a medical device manufacturing company, offers biotech services in the United States. The company develops and markets BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume.
View More 
0.91%